Yuki Enoki Selected Research

AST 120

1/2023	The G protein-coupled receptor ligand apelin-13 ameliorates skeletal muscle atrophy induced by chronic kidney disease.
1/2020	Indoxyl Sulfate Contributes to Adipose Tissue Inflammation through the Activation of NADPH Oxidase.
10/2017	Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuki Enoki Research Topics

Disease

12	Infections 06/2023 - 01/2014
7	Neoplasms (Cancer) 05/2024 - 05/2019
7	Clostridium Infections 10/2023 - 11/2018
7	Chronic Renal Insufficiency 10/2023 - 01/2016
6	Poisoning 10/2023 - 10/2021
5	Atrophy 05/2024 - 01/2016
4	Muscular Atrophy (Muscle Atrophy) 01/2023 - 01/2016
3	Pneumonia (Pneumonitis) 07/2023 - 01/2021
3	Bacterial Meningitis 08/2022 - 09/2021
3	Meningitis 08/2022 - 09/2021
3	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 01/2019
3	Sarcopenia 12/2021 - 01/2016
2	Fibrosis (Cirrhosis) 10/2023 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 01/2020
2	Acidosis 01/2023 - 01/2022
2	Sepsis (Septicemia) 01/2023 - 01/2022
2	Thrombocytopenia (Thrombopenia) 11/2022 - 01/2019
2	Rhabdomyolysis 01/2022 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2021 - 10/2017
2	Invasive Candidiasis 11/2021 - 11/2020
2	Candidemia 07/2021 - 11/2020
2	Secondary Hyperparathyroidism 12/2017 - 01/2017
2	Human Influenza (Influenza) 01/2015 - 01/2014
2	Virus Diseases (Viral Diseases) 01/2015 - 01/2014
2	Lung Injury 01/2015 - 01/2014
1	Cardiotoxicity 05/2024
1	Critical Illness (Critically Ill) 11/2023
1	Edema (Dropsy) 11/2023
1	Diarrhea 10/2023
1	Ureteral Obstruction 10/2023
1	Hepatocellular Carcinoma (Hepatoma) 10/2023
1	Endocarditis 01/2023
1	Weight Loss (Weight Reduction) 01/2023
1	Foreign Bodies (Foreign Body) 01/2023
1	Osteomyelitis 01/2023
1	Kidney Diseases (Kidney Disease) 01/2023
1	Lung Diseases (Lung Disease) 11/2022
1	Bacteremia 03/2022

Drug/Important Bio-Agent (IBA)

10	Vancomycin FDA LinkGeneric 11/2023 - 11/2018
7	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2014
7	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 01/2015
6	AntidotesIBA 10/2023 - 10/2021
6	IndicanIBA 10/2023 - 01/2016
5	AlbuminsIBA 05/2024 - 12/2021
4	Carbon MonoxideIBA 05/2024 - 01/2020
4	MethemoglobinIBA 10/2023 - 10/2021
4	Metronidazole (Metric)FDA LinkGeneric 07/2023 - 11/2018
4	MyostatinIBA 01/2023 - 01/2016
4	Daptomycin FDA Link 01/2023 - 06/2021
4	Cyanides (Isocyanides)IBA 01/2023 - 10/2021
4	EchinocandinsIBA 07/2021 - 06/2020
3	tedizolidIBA 11/2023 - 01/2022
3	Human Serum Albumin FDA LinkGeneric 10/2023 - 01/2014
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2023 - 01/2022
3	AST 120IBA 01/2023 - 10/2017
3	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2023 - 10/2021
3	Linezolid (Zyvox)FDA Link 11/2022 - 09/2021
3	Uremic ToxinsIBA 01/2020 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2022
2	TeicoplaninIBA 10/2023 - 01/2021
2	Hemoglobins (Hemoglobin)IBA 06/2023 - 12/2021
2	Glucose (Dextrose)FDA LinkGeneric 06/2023 - 01/2022
2	FidaxomicinIBA 05/2023 - 11/2022
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 08/2022 - 12/2019
2	Cytochrome P-450 CYP3AIBA 01/2022 - 12/2017
2	Therapeutic UsesIBA 01/2022 - 01/2022
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 10/2017
2	Liposomes (Liposome)IBA 12/2021 - 10/2021
2	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2021 - 01/2020
2	beta-Lactamases (beta-Lactamase)IBA 11/2021 - 01/2021
2	A-factor (Streptomyces)IBA 10/2021 - 12/2019
2	Cystatin CIBA 06/2021 - 01/2021
2	PolyenesIBA 11/2020 - 11/2020
2	Sulfates (Sulfates, Inorganic)IBA 01/2020 - 02/2015
2	Parathyroid Hormone (Parathormone)IBA 12/2017 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015 - 01/2014
2	Hydroxyl RadicalIBA 01/2015 - 01/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2024
1	CarrageenanIBA 11/2023
1	PowdersIBA 10/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2023
1	cefditoren pivoxil (Spectracef)FDA Link 07/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Charcoal (Charbon)IBA 01/2023
1	Sodium NitriteIBA 01/2023
1	phenyl-2-aminoethyl sulfide (PAES)IBA 01/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	Apelin ReceptorsIBA 01/2023
1	ApelinIBA 01/2023
1	LigandsIBA 01/2023
1	apelin-13 peptideIBA 01/2023
1	Ceftazidime (Fortum)FDA LinkGeneric 08/2022
1	NivolumabIBA 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2022

Therapy/Procedure

7	Therapeutics 05/2024 - 11/2018
2	Aftercare (After-Treatment) 10/2023 - 01/2022
2	Nephrectomy 10/2023 - 01/2023
1	Denervation 01/2023
1	Punctures 01/2023
1	Ligation 01/2023